MENU
+Compare
QURE
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$14.25
Change
-$0.14 (-0.97%)
Capitalization
771.14M

QURE uniQure NV Forecast, Technical & Fundamental Analysis

uniQure NV is a gene therapy company... Show more

Industry: #Biotechnology
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for QURE with price predictions
Apr 23, 2025

QURE in upward trend: price rose above 50-day moving average on April 17, 2025

QURE moved above its 50-day moving average on April 17, 2025 date and that indicates a change from a downward trend to an upward trend. In of 44 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on QURE as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for QURE just turned positive on April 17, 2025. Looking at past instances where QURE's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where QURE advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for QURE crossed bearishly below the 50-day moving average on March 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QURE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

QURE broke above its upper Bollinger Band on April 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. QURE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.739) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (25.575) is also within normal values, averaging (252.992).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QURE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

QURE is expected to report earnings to fall 32.89% to -100 cents per share on May 13

uniQure NV QURE Stock Earnings Reports
Q1'25
Est.
$-1.00
Q4'24
Missed
by $0.82
Q3'24
Beat
by $0.11
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.08
The last earnings report on February 27 showed earnings per share of -149 cents, missing the estimate of -67 cents. With 1.05M shares outstanding, the current market capitalization sits at 771.14M.
A.I. Advisor
published General Information

General Information

a company which engages in the discovery, development, and commercialization of gene therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRIEX12.69N/A
N/A
Meridian Hedged Equity Investor
CSGYX24.37N/A
N/A
Columbia Small Cap Growth Inst3
SGACX17.89N/A
N/A
Virtus SGA Global Growth C
FHJUX38.97N/A
N/A
Fidelity Advisor Europe A
TRZRX14.43N/A
N/A
T. Rowe Price Real Assets Z

QURE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with CMRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
N/A
CMRX - QURE
52%
Loosely correlated
N/A
NAMS - QURE
52%
Loosely correlated
+2.86%
HOOK - QURE
44%
Loosely correlated
+4.00%
AXON - QURE
42%
Loosely correlated
+3.82%
ABSI - QURE
38%
Loosely correlated
-0.47%
More